Evolus Inc., a performance beauty company, announced the approval of non-qualified stock options and restricted stock units (RSUs) for 16 newly hired non-executive employees under its 2023 Inducement Incentive Plan. The compensation package includes stock options to purchase 12,706 shares at an exercise price of $9.98 per share, reflecting the closing price on the grant date of May 12, 2025. These options have a 10-year term and will vest over four years, with 25% vesting annually. Additionally, 40,576 RSUs were granted, also vesting at 25% annually starting from May 7, 2025. These awards are contingent upon continuous employment with Evolus.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.